Metabolic syndrome correlates with polyvascular lesions detected by systemic vascular ultrasonography in Japanese people with type 2 diabetes

Diabetes Research and Clinical Practice

Volumn 96, Issue 2, 2012, Pages

  Hirata, Ayumu ^a   Kishida, Ken ^a   Nakatsuji, Hideaki ^a   Hiuge Shimizu, Aki ^a   Funahashi, Tohru ^a   Shimomura, Iichiro ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

Metabolic syndrome; Systemic atherosclerosis; Vascular ultrasonography

Indexed keywords

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CLINICAL FEATURE; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ECHOGRAPHY; FEMALE; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK ASSESSMENT; VASCULAR LESION;

ADULT; AGED; AGED, 80 AND OVER; ATHEROSCLEROSIS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED;

EID: 84860513043     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2012.01.020     Document Type: Article

References (13)

1. Dilic M., Dzubur A., Kusljugic Z., Balic S., Pepic E. Correlation of arterial hypertension and type 2 diabetes mellitus with type of polyvascular atherosclerotic disease. Med Arh 2010, 64:264-268.
2. Djaberi R., Schuijf J.D., de Koning E.J., Rabelink T.J., Smit J.W., Kroft L.J., et al. Usefulness of carotid intima-media thickness in patients with diabetes mellitus as a predictor of coronary artery disease. Am J Cardiol 2009, 104:1041-1046.
3. Herder C., Karakas M., Koenig W. Biomarkers for the prediction of type 2 diabetes and cardiovascular disease. Clin Pharmacol Ther 2011, 90:52-66.
4. Hirata A., Kishida K., Hiuge-Shimizu A., Nakatsuji H., Funahashi T., Shimomura I. Qualitative score of systemic arteriosclerosis by vascular ultrasonography as a predictor of coronary artery disease in type 2 diabetes. Atherosclerosis 2011, 219:623-629.
5. Ryo M., Maeda K., Onda T., Katashima M., Okumiya A., Nishida M., et al. A new simple method for the measurement of visceral fat accumulation by bioelectrical impedance. Diabetes Care 2005, 28:451-453.
6. Nakatsuji H., Kishida K., Funahashi T., Shimomura I. Three-month treatment with pioglitazone reduces circulating levels of thiobarbituric acid-reacting substances, a marker of reactive oxidative stress, without change in body mass index, in Japanese patients with type 2 diabetes. Atherosclerosis 2010, 212:243-245. Senri Study II Group.
7. Nakagawa Y., Kishida K., Mazaki T., Yokoi H., Nobuyoshi M., Funahashi T., et al. Impact of sleep-disordered breathing, visceral fat accumulation and adiponectin levels in patients with night-time onset of acute coronary syndrome. Am J Cardiol 2011, 108:1266-1271.
8. Nakatsuji H., Kishida K., Funahashi T., Shimomura I The Senri Study II Group. Three-month treatment with pioglitazone reduces circulating levels of S100A8/A9 (MRP8/14) complex, a biomarker of inflammation, without changes in body mass index, in type 2 diabetics with abdominal obesity. Diabetes Res Clin Pract 2011, http://pdn.sciencedirect.com/science%3F_ob=MiamiImageURL%26_cid=271273%26_user=9152734%26_pii=S0168822711006413%26_check=y%26_origin=article%26_zone=toolbar%26_coverDate=09-Dec-2011%26view=c%26originContentFamily=serial%26wchp=dGLzVlk-zSkWb%26md5=637a45661bf35470d40274e46f3e4340/1-s2.0-S0168822711006413-main.pdf.
9. Teramoto T., Sasaki J., Ueshima H., Egusa G., Kinoshita M., Shimamoto K., et al. Metabolic syndrome. J Atheroscler Thromb 2008, 15:1-5.
10. Okauchi Y., Kishida K., Funahashi T., Noguchi M., Ogawa T., Ryo M., et al. Changes in serum adiponectin concentrations correlate with changes in BMI, waist circumference, and estimated visceral fat area in middle-aged general population. Diabetes Care 2009, 32:e122.
11. Okauchi Y., Kishida K., Funahashi T., Noguchi M., Ogawa T., Okita K., et al. Cross-sectional and longitudinal study of association between circulating thiobarbituric acid-reacting substance levels and clinicobiochemical parameters in 1178 middle-aged Japanese men - the Amagasaki Visceral Fat Study. Nutr Metab (Lond) 2011, 8:82.
12. Okauchi Y., Nishizawa H., Funahashi T., Ogawa T., Noguchi M., Ryo M., et al. Reduction of visceral fat is associated with decrease in the number of metabolic risk factors in Japanese men. Diabetes Care 2007, 30:2392-2394.
13. Okauchi Y., Kishida K., Funahashi T., Noguchi M., Morita S., Ogawa T., et al. 4-year follow-up of cardiovascular events and changes in visceral fat accumulation after health promotion program in the Amagasaki Visceral Fat Study. Atherosclerosis 2010, 212:698-700.